Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Aurinia Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$7.5

2024-10-29

Market Capitalization

$1.1 B

2024-10-29

Revenue

$283.1 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue463.0K318.0K50.1M45.6M134.0M175.5M235.1M283.1M
Cost of goods sold1.1M5.7M13.5M8.8M13.2M
Gross profit463.0K372.0K50.1M44.5M129.9M162.0M230.7M269.8M
Gross profit margin, %117.0%100.0%97.6%96.9%92.3%98.1%95.3%
Operating expense total55.3M84.1M153.1M223.2M240.7M253.1M215.9M145.5M
Depreciation and amortization1.6M1.5M1.3M2.1M629.0K606.0K19.4M19.4M
EBITDA(54.8M)(83.8M)(103.0M)(178.6M)(110.8M)(91.1M)14.8M124.4M
EBITDA margin, %-26337.4%-205.5%-391.7%-82.7%-51.9%6.3%43.9%
EBIT(56.4M)(85.3M)(104.3M)(180.7M)(111.5M)(91.7M)(4.7M)104.9M
EBIT margin, %-26824.2%-208.1%-396.3%-83.2%-52.2%-2.0%37.1%
Interest income2.2M2.7M1.5M529.0K5.1M17.0M17.0M13.6M
Interest expense39.0K2.8M4.8M4.3M
Pre tax profit(64.0M)(123.7M)(102.8M)(180.2M)(106.4M)(77.5M)7.4M114.2M
Income tax expense73.0K144.0K(94.0K)760.0K1.8M551.0K1.7M(173.0M)
Net Income(64.1M)(123.8M)(102.7M)(181.0M)(108.2M)(78.0M)5.8M287.2M

Footer menu